Fresenius Short Term Debt vs Other Stockholder Equity Analysis

0H9X Stock

45.50 0.05 0.11%

Fresenius Medical financial indicator trend analysis is much more than just examining Fresenius Medical Care latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fresenius Medical Care is a good investment. Please check the relationship between Fresenius Medical Short Term Debt and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Short Term Debt vs Other Stockholder Equity

Short Term Debt vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fresenius Medical Care Short Term Debt account and Other Stockholder Equity. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Fresenius Medical's Short Term Debt and Other Stockholder Equity is -0.07. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Fresenius Medical Care, assuming nothing else is changed. The correlation between historical values of Fresenius Medical's Short Term Debt and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Fresenius Medical Care are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Short Term Debt i.e., Fresenius Medical's Short Term Debt and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.07

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Short Term Debt

Other Stockholder Equity

Most indicators from Fresenius Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tax Provision is likely to drop to about 397.1 M in 2024. Selling General Administrative is likely to drop to about 2.4 B in 2024

	2019	2020	2023	2024 (projected)
Interest Income	429.4M	368.0M	423.2M	401.9M
Tax Provision	401.6M	500.6M	450.5M	397.1M

Interest Income Tax Provision

Fresenius Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Other Liab	Net Tangible Assets
Total Assets		0.95	0.92	0.88	0.93	0.22	0.93	0.45	0.32	0.92	0.76	-0.36	-0.91	0.93	0.84	-0.22	0.99	0.82	-0.92	-0.47	0.97	-0.66	0.98	0.89	0.88	-0.93
Short Long Term Debt Total	0.95		0.79	0.7	0.83	-0.03	0.82	0.6	0.06	0.78	0.69	-0.22	-0.88	0.89	0.85	-0.21	0.99	0.69	-0.91	-0.61	0.99	-0.53	0.96	0.88	0.84	-0.91
Total Current Liabilities	0.92	0.79		0.93	0.93	0.46	0.96	0.19	0.53	0.94	0.65	-0.52	-0.83	0.85	0.65	-0.25	0.86	0.84	-0.86	-0.29	0.84	-0.66	0.9	0.82	0.75	-0.87
Total Stockholder Equity	0.88	0.7	0.93		0.9	0.59	0.92	0.12	0.68	0.95	0.68	-0.52	-0.78	0.81	0.67	-0.22	0.8	0.87	-0.76	-0.18	0.76	-0.7	0.82	0.75	0.77	-0.78
Retained Earnings	0.93	0.83	0.93	0.9		0.5	0.99	0.19	0.55	0.93	0.53	-0.59	-0.94	0.93	0.83	-0.39	0.89	0.86	-0.91	-0.43	0.88	-0.66	0.94	0.92	0.88	-0.89
Cash	0.22	-0.03	0.46	0.59	0.5		0.52	-0.65	0.97	0.45	-0.12	-0.63	-0.26	0.27	0.16	-0.43	0.09	0.46	-0.21	0.31	0.07	-0.24	0.21	0.22	0.22	-0.2
Other Assets	0.93	0.82	0.96	0.92	0.99	0.52		0.15	0.58	0.91	0.53	-0.55	-0.91	0.89	0.79	-0.41	0.88	0.84	-0.91	-0.37	0.88	-0.63	0.94	0.89	0.82	-0.9
Long Term Debt	0.45	0.6	0.19	0.12	0.19	-0.65	0.15		-0.5	0.28	0.69	0.44	-0.43	0.47	0.47	0.43	0.54	0.35	-0.3	-0.74	0.51	-0.4	0.39	0.47	0.53	-0.32
Cash And Short Term Investments	0.32	0.06	0.53	0.68	0.55	0.97	0.58	-0.5		0.53	0.03	-0.49	-0.34	0.36	0.24	-0.31	0.19	0.59	-0.24	0.24	0.16	-0.32	0.28	0.3	0.31	-0.25
Net Receivables	0.92	0.78	0.94	0.95	0.93	0.45	0.91	0.28	0.53		0.73	-0.51	-0.84	0.92	0.69	-0.08	0.86	0.93	-0.79	-0.34	0.82	-0.74	0.87	0.82	0.86	-0.8
Good Will	0.76	0.69	0.65	0.68	0.53	-0.12	0.53	0.69	0.03	0.73		-0.04	-0.58	0.64	0.53	0.3	0.75	0.65	-0.54	-0.39	0.68	-0.72	0.64	0.57	0.66	-0.6
Short Term Investments	-0.36	-0.22	-0.52	-0.52	-0.59	-0.63	-0.55	0.44	-0.49	-0.51	-0.04		0.41	-0.37	-0.31	0.59	-0.29	-0.3	0.5	-0.06	-0.29	0.38	-0.42	-0.38	-0.36	0.45
Capital Surpluse	-0.91	-0.88	-0.83	-0.78	-0.94	-0.26	-0.91	-0.43	-0.34	-0.84	-0.58	0.41		-0.95	-0.92	0.27	-0.9	-0.83	0.9	0.72	-0.89	0.76	-0.92	-0.99	-0.96	0.89
Inventory	0.93	0.89	0.85	0.81	0.93	0.27	0.89	0.47	0.36	0.92	0.64	-0.37	-0.95		0.85	-0.12	0.92	0.91	-0.84	-0.62	0.9	-0.68	0.91	0.94	0.96	-0.83
Other Current Assets	0.84	0.85	0.65	0.67	0.83	0.16	0.79	0.47	0.24	0.69	0.53	-0.31	-0.92	0.85		-0.4	0.85	0.68	-0.83	-0.7	0.84	-0.65	0.85	0.91	0.92	-0.8
Other Stockholder Equity	-0.22	-0.21	-0.25	-0.22	-0.39	-0.43	-0.41	0.43	-0.31	-0.08	0.3	0.59	0.27	-0.12	-0.4		-0.2	0.05	0.42	-0.07	-0.26	-0.08	-0.33	-0.28	-0.13	0.33
Total Liab	0.99	0.99	0.86	0.8	0.89	0.09	0.88	0.54	0.19	0.86	0.75	-0.29	-0.9	0.92	0.85	-0.2		0.77	-0.92	-0.55	0.99	-0.61	0.98	0.89	0.87	-0.93
Total Current Assets	0.82	0.69	0.84	0.87	0.86	0.46	0.84	0.35	0.59	0.93	0.65	-0.3	-0.83	0.91	0.68	0.05	0.77		-0.64	-0.45	0.71	-0.73	0.75	0.82	0.87	-0.66
Treasury Stock	-0.92	-0.91	-0.86	-0.76	-0.91	-0.21	-0.91	-0.3	-0.24	-0.79	-0.54	0.5	0.9	-0.84	-0.83	0.42	-0.92	-0.64		0.51	-0.94	0.6	-0.97	-0.88	-0.8	0.99
Short Term Debt	-0.47	-0.61	-0.29	-0.18	-0.43	0.31	-0.37	-0.74	0.24	-0.34	-0.39	-0.06	0.72	-0.62	-0.7	-0.07	-0.55	-0.45	0.51		-0.53	0.61	-0.51	-0.74	-0.72	0.49
Intangible Assets	0.97	0.99	0.84	0.76	0.88	0.07	0.88	0.51	0.16	0.82	0.68	-0.29	-0.89	0.9	0.84	-0.26	0.99	0.71	-0.94	-0.53		-0.54	0.98	0.88	0.84	-0.94
Common Stock	-0.66	-0.53	-0.66	-0.7	-0.66	-0.24	-0.63	-0.4	-0.32	-0.74	-0.72	0.38	0.76	-0.68	-0.65	-0.08	-0.61	-0.73	0.6	0.61	-0.54		-0.61	-0.75	-0.79	0.63
Property Plant Equipment	0.98	0.96	0.9	0.82	0.94	0.21	0.94	0.39	0.28	0.87	0.64	-0.42	-0.92	0.91	0.85	-0.33	0.98	0.75	-0.97	-0.51	0.98	-0.61		0.91	0.85	-0.97
Other Current Liab	0.89	0.88	0.82	0.75	0.92	0.22	0.89	0.47	0.3	0.82	0.57	-0.38	-0.99	0.94	0.91	-0.28	0.89	0.82	-0.88	-0.74	0.88	-0.75	0.91		0.94	-0.86
Other Liab	0.88	0.84	0.75	0.77	0.88	0.22	0.82	0.53	0.31	0.86	0.66	-0.36	-0.96	0.96	0.92	-0.13	0.87	0.87	-0.8	-0.72	0.84	-0.79	0.85	0.94		-0.79
Net Tangible Assets	-0.93	-0.91	-0.87	-0.78	-0.89	-0.2	-0.9	-0.32	-0.25	-0.8	-0.6	0.45	0.89	-0.83	-0.8	0.33	-0.93	-0.66	0.99	0.49	-0.94	0.63	-0.97	-0.86	-0.79

Click cells to compare fundamentals

Fresenius Medical Account Relationship Matchups

Fresenius Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	24.0B	26.2B	32.9B	31.7B	36.4B	30.9B
Short Long Term Debt Total	5.8B	5.0B	10.5B	10.7B	12.3B	8.6B
Total Current Liabilities	7.1B	6.1B	7.3B	6.5B	7.4B	6.9B
Total Stockholder Equity	9.8B	11.8B	12.0B	11.2B	12.9B	12.0B
Retained Earnings	9.5B	10.3B	10.8B	10.7B	12.3B	9.9B
Cash	358.0M	1.3B	239.0M	334.7M	384.9M	503.2M
Other Assets	1.1B	1.1B	1.2B	1.1B	1.3B	1.1B
Long Term Debt	5.8B	5.0B	6.5B	6.8B	7.8B	6.8B
Cash And Short Term Investments	993.6M	2.3B	1.1B	1.2B	1.4B	1.5B
Net Receivables	4.0B	3.6B	3.9B	4.0B	4.6B	4.1B
Good Will	12.1B	12.2B	14.0B	13.0B	14.9B	14.1B
Short Term Investments	15.5M	119.5M	133.3M	161.7M	145.5M	108.9M
Capital Surpluse	4.0B	3.9B	3.6B	2.9B	2.6B	2.9B
Inventory	1.7B	1.9B	2.0B	2.3B	2.6B	1.9B
Other Current Assets	306.6M	462.2M	346.3M	370.8M	426.5M	361.6M
Other Stockholder Equity	(1.0B)	(2.2B)	(1.3B)	(388.5M)	(349.6M)	(367.1M)
Total Liab	14.2B	14.5B	21.0B	20.5B	23.5B	18.8B
Total Current Assets	7.2B	7.3B	8.0B	8.2B	9.4B	8.1B
Short Term Debt	769.3M	1.4B	1.2B	79.3M	71.3M	67.8M
Intangible Assets	683.1M	681.3M	1.4B	1.4B	1.6B	1.1B
Common Stock	304.4M	292.9M	293.0M	293.4M	264.1M	240.8M
Property Plant Equipment	8.5B	8.2B	8.6B	8.3B	9.6B	7.0B
Other Current Liab	1.8B	2.4B	2.6B	2.3B	2.7B	2.4B
Other Liab	2.1B	2.6B	2.4B	2.7B	3.1B	2.6B
Net Tangible Assets	(3.5B)	(3.1B)	(3.1B)	(3.3B)	(3.0B)	(3.1B)
Accounts Payable	756.2M	794.9M	818.5M	892.6M	1.0B	872.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fresenius Short Term Debt vs Other Stockholder Equity Analysis

Short Term Debt vs Other Stockholder Equity

Short Term Debt vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Short Term Debt

Other Stockholder Equity

Fresenius Medical fundamental ratios Correlations

Fresenius Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Fresenius Medical fundamental ratios Accounts

Also Currently Popular

Additional Tools for Fresenius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Assets
Total Liab	+ 0.99	Short Long Term Debt Total
Intangible Assets	+ 0.99	Short Long Term Debt Total
Other Assets	+ 0.99	Retained Earnings
Intangible Assets	+ 0.99	Total Liab
Net Tangible Assets	+ 0.99	Treasury Stock

Other Current Liab	- 0.99	Capital Surpluse
Net Tangible Assets	- 0.97	Property Plant Equipment
Property Plant Equipment	- 0.97	Treasury Stock
Other Liab	- 0.96	Capital Surpluse
Inventory	- 0.95	Capital Surpluse
Net Tangible Assets	- 0.94	Intangible Assets